Evidence map›Paper›PMID 38689064›Full record

ArticleSchmerz (Berlin, Germany)2024

[Trigeminal neuralgia: drug therapy : The new German guideline].

Ruth Ruscheweyh, Janne Gierthmühlen, Dennis M Hedderich, Gudrun Goßrau, Stefan Leis

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Schmerz (Berlin, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. [Surgical treatment of trigeminal pain].Schmerz (Berlin, Germany) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ruth RuscheweyhNeurologische Klinik und Poliklinik, LMU Klinikum, LMU München, Marchioninistr. 15, 81377, München, Deutschland. ruth.ruscheweyh@med.uni-muenchen.de.
Janne GierthmühlenInterdisziplinäres Zentrum für Schmerz- und Palliativmedizin, Klinik für Anästhesiologie und Operative Intensivmedizin, Universitätsklinikum Schleswig-Holstein, Campus Kiel, Kiel, Deutschland.
Dennis M HedderichAbteilung für Diagnostische und Interventionelle Neuroradiologie, Klinikum rechts der Isar, School of Medicine and Health, Technische Universität München, München, Deutschland.
Gudrun GoßrauKopfschmerzambulanz, Interdisziplinäres UniversitätsSchmerzCentrum, Medizinische Fakultät, Universitätsklinikum Dresden, TU Dresden, Dresden, Deutschland.
Stefan LeisChristian-Doppler-Klinik, Universitätsklinik für Neurologie, neurologische Intensivmedizin und Neurorehabilitation, Paracelsus Medizinische Universität, Salzburg, Österreich.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Trigeminal neuralgia is characterized by severe, lightning-like attacks of pain, which are mandatory for the diagnosis. The pain typically occurs on one side and is often triggered by simply touching the face, chewing or talking. In acute exacerbations, this can also hinder food and fluid intake, resulting in a life-threatening clinical picture. A distinction is made between classical, secondary and idiopathic trigeminal neuralgia. For the diagnosis of trigeminal neuralgia, the medical history and imaging procedures are key for classification. The only active substances approved for the treatment of trigeminal neuralgia in Germany are carbamazepine and phenytoin, which is why off-label drugs often need to be used if there is no or insufficient effect or inacceptable side effects. Cooperation between research and clinical practice to improve the care of affected patients is therefore essential.

Indexed as

CarbamazepinePhenytoinTrigeminal NeuralgiaAnticonvulsantsCooperative BehaviorDiagnosis, DifferentialGermanyGuideline AdherenceHumansInterdisciplinary CommunicationIntersectoral CollaborationOff-Label UsePractice Guidelines as TopicAnticonvulsantsCarbamazepinePhenytoinCarbamazepineFacial painOxcarbazepineTrigeminal neuralgia/imagingTrigeminal neuralgia/invasive therapy

Identifiers

PMID38689064

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.